Thursday 31 March 2011

Peritoneal Mesothelioma

Peritoneal Mesothelioma is a rare type of mesothelioma accounts for only 10-20% of all mesothelioma diagnosis, about 3,000 cases diagnosed each year in the United States. This cancer develops in the mesothelium cell layer on the peritoneum.

Peritoneal Mesothelioma is also exposed to asbestos as causing all types of mesothelioma. For less common as the type of mesothelioma is peritoneal mesothelioma has a latency of 20-30years after asbestos exposure, compared with the period of 30 to40 years in cases of pleural mesothelioma. Presenting with a survival time from 7 to 13.5 months with a poor prognosis.

Associated symptoms include abdominal pain, swelling or changes in bowel habits such as diarrhea or constipation. Other formations include abdominal lump under the skin and weight loss of unknown origin. Nausea, vomiting, fatigue, night sweats and fever are also common.
In many cases, there may be cases related to the anemia.
As can be the case for many patients with generalized symptoms and bowel obstruction and cachexia results in severe abdominal pain and malignant as cites resulting in abdominal distention due to progressive tumor growth in the peritoneum.

The diagnosis of mesothelioma cannot be generalized to symptoms alone, especially in the case of peritoneal mesothelioma. The diagnosis in these cases begins with a detailed examination of the history; natural history is followed by imaging together with testing of body fluids and tissues of patients with mesothelioma.
Any physical abnormality is detected by the use of more sophisticated and reliable techniques, such as CT scans and radiographs. To confirm the presence of cancer using tissue biopsy is well represented in the diagnosis of mesothelioma. It is a minor surgical procedure that involves the removal of fluid or tissue of the peritoneum.
To verify the presence of mesothelioma cells after the biopsy, the fluid and tissues tested in the laboratory. When it is found that the patient is indeed suffering from peritoneal mesothelioma doctor mesothelioma patient and together form a treatment plan.

For peritoneal mesothelioma, the disease progression is much faster for diagnosis in most cases performed in the latter stages of the disease. Here the treatment becomes difficult, because the cancer is in the later stages of development. Doctors often advise patients of mesothelioma treatment for combating cancer and to relieve pain.
The common treatment of patients with peritoneal mesothelioma generally may include surgery, radiation and chemotherapy treatments to all types of mesothelioma.

Mesothelioma patients can undergo a combination of treatments for peritoneal mesothelioma and no known cure for the disease. Participation in clinical trials for pain relief and improved quality of life is another approach that patients can opt for mesothelioma. These are the patients to test new medicines and future disease.

Many mesothelioma patients treated hyperthermia intraperitonealchemotherapy (HIPEC). In this case, a higher concentration of the chemotherapy solution is directly injected directly into the abdominal cavity after surgery, so it is the killing of cancer cells in the abdominal cavity more that chemotherapy is given through a vein route.
Many times before surgery, patients with mesothelioma can go through radiation therapy to shrink tumors.
Most mesothelioma patients need to have cytoreduction surgery (CRS), which is subjected to as much cancerous tissue in the abdomen as possible, eliminated, making the "most " of cancer is also called "debulking" surgery.

Many patients with peritoneal mesothelioma can choose to participate in palliative care do not try to cure a patient in the workplace and improve the quality of life for them.

For more information: http://mesoblog.org/blog/


No comments:

Post a Comment